tiprankstipranks
Sonnet BioTherapeutics Regains Compliance, Risks Nasdaq Delisting
PremiumCompany AnnouncementsSonnet BioTherapeutics Regains Compliance, Risks Nasdaq Delisting
3M ago
Sonnet BioTherapeutics Navigates Financial Compliance Hurdles
PremiumCompany Announcements
Sonnet BioTherapeutics Navigates Financial Compliance Hurdles
3M ago
Sonnet BioTherapeutics files $100M mixed securities shelf
PremiumThe Fly
Sonnet BioTherapeutics files $100M mixed securities shelf
4M ago
Sonnet announces results of biodistribution studies using FHAB technology
PremiumThe FlySonnet announces results of biodistribution studies using FHAB technology
7M ago
Sonnet BioTherapeutics files to sell common stock, no amount given
PremiumThe Fly
Sonnet BioTherapeutics files to sell common stock, no amount given
7M ago
Sonnet BioTherapeutics announces 1-for-22 reverse stock split
PremiumThe Fly
Sonnet BioTherapeutics announces 1-for-22 reverse stock split
8M ago
Sonnet BioTherapeutics files to sell 5.15M shares of common stock for holders
PremiumThe FlySonnet BioTherapeutics files to sell 5.15M shares of common stock for holders
9M ago
Sonnet BioTherapeutics announces $2.25M registered direct offering
PremiumThe Fly
Sonnet BioTherapeutics announces $2.25M registered direct offering
10M ago
Sonnet BioTherapeutics to present at Cytokine-Based Drug Development Summit
PremiumThe Fly
Sonnet BioTherapeutics to present at Cytokine-Based Drug Development Summit
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100